Hepatic Artery Infusion (Hai) of Irinotecan, 5-Fluorouracil, and Oxaliplatin plus Intravenous Cetuximab (Cet) (Optiliv) After Failure on One Versus Two or Three Chemotherapy Protocols in Patients (Pts) with Unresectable Liver Metastases from Wt Kras Colorectal Cancer (Lm-Crc) (European Phase Ii Clinical Trial Nct00852228).
AuthID
P-00P-8PW
P-00P-8PW